Swiss Lonza 2012 net profit up 18.2% as sales surge 45.8%
24 January 2013 07:04 [Source: ICIS news]
SINGAPORE (ICIS)--Switzerland’s Lonza reported on Thursday an 18.2% year-on-year increase in its net profit to Swiss francs (Swfr) 182m ($196m, €147m) for the full year of 2012, as sales surged following its acquisition of US Arch Chemicals.
The company’s sales rose by 45.8% year on year to Swfr3.93bn in 2012, while its earnings before interest, tax, depreciation and amortisation (EBITDA) was up by 19.2% at Swfr640m, the pharmaceutical-ingredients maker said in a statement.
“The volatile macroeconomic situation was challenging, but Lonza managed to balance most of the risks by delivering its extensive product portfolio to a diverse set of markets,” it added.
Looking ahead, Lonza said that “2013 is likely to bring further macroeconomic challenges”.
The company expects further sales and growth in earnings before interest and taxes (EBIT) in 2013 and confirms that it is targeting an EBITDA margin of 20% by 2015.
It reported an EBITDA margin of 16.3% in 2012, down from 19.9% in 2011.
The company did not report quarterly figures in the trading statement.
($1 = Swfr0.93, €0.75)By: Nurluqman Suratman
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial
to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free
trial to ICIS Chemical Business.